High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea Massachusetts.
Detection Principle
ImmunoAssay-Antibody
Target
IgM, IgG vs RBD
Testing Method Category
LFIA
Testing Method
kit (Biomedocmics)
Testing Method - Additional Info
BioMedomics SARS-CoV-2 (IgM/IgG) lateral flow immunoassay (LFA) point-of-care (POC) as a laboratory-developed test
Reported Performance
sensitivity: 80% (IgM), 85% (IgG), and 90% (combined IgM or IgG >14 dpo); Specificity: >99%
Sample Size
57 samples (validation), 374 (pre-covid samples for specificity)
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements